Status:
UNKNOWN
Effectiveness and Safety of Implantable Intrathecal Systems for Refractory Pain in Spain (INTRATHECAL-RENASED)
Lead Sponsor:
Sociedad Espanola del Dolor
Conditions:
Refractory Pain
Eligibility:
All Genders
18+ years
Brief Summary
Refractory pain is a prevalent condition that negatively affects patients' quality of life. Intrathecal implantable systems have been proposed as a treatment option for refractory pain. However, real-...
Detailed Description
All Spanish hospitals that implant intrathecal systems for refractory pain will be invited to participate in the study. Patients will be recruited before the procedure, and before providing data to th...
Eligibility Criteria
Inclusion
- Chronic refractory pain patients candidates for treatment with an implantable neurostimulation system.
- Accept to participate in the study and sign informed consent.
Exclusion
- Patients in whom it would be difficult to complete follow-up.
- Insufficient understanding of the Spanish language.
- Pregnancy.
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
504 Patients enrolled
Trial Details
Trial ID
NCT05970081
Start Date
August 1 2023
End Date
August 1 2025
Last Update
May 22 2024
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Regional Univeristario de Málaga
Málaga, Andalusia, Spain, 29010
2
Hospital Universitari Son Espases
Palma de Mallorca, Balearic Island, Spain, 07120
3
Hospital Universitario de Navarra
Pamplona, Navarre, Spain, 31008
4
Hospital Clinic de Barcelona
Barcelona, Spain, 08036